Disclosure: This article contains affiliate links. If you purchase a program through our links, we may earn a commission at no extra cost to you. Opinions are our own.
Medical Disclaimer: This article is for informational purposes only and is not medical advice. GLP-1 medications require a prescription from a licensed provider. Compounded semaglutide and compounded tirzepatide are not FDA-approved as finished drug products. Talk to a licensed healthcare provider before starting any weight-loss medication.
TrimRx and Hers both connect patients with GLP-1 weight-loss medication online. But they price and structure that access very differently.
Hers has the backing of a large public company and a strong track record. TrimRx has a simpler, more transparent bill.
After comparing medications, pricing, and how each platform actually works, TrimRx comes out ahead for most patients.
Overall Rating: TrimRx 3.6/5 | Hers 3.4/5
Quick Verdict: TrimRx wins on pricing transparency and total cost, since it charges one flat monthly price with no separate membership fee. Hers is a legitimate, well-run option, but its $149/mo membership stacks on top of medication costs and can surprise patients.
What Is TrimRx
TrimRx is a GLP-1 platform offering both compounded and brand-name semaglutide and tirzepatide under one roof. It charges a single flat monthly price with no separate membership fee.
TrimRx Pros
- No separate membership fee stacked on top of medication cost
- Offers both compounded and brand-name GLP-1 options in one place
- Compounded plans are available month-to-month, without a mandatory long prepay
- Guaranteed pricing as dosing changes over time
- Dual LegitScript certification and a 3-month results guarantee
TrimRx Cons
- Multi-month plans require upfront billing to get the lower rate
- Trustpilot reviews are mixed, and Reddit sentiment runs harsher
- BBB accredited only since June 2025, with active complaints and no rating yet
- A minor founder-name discrepancy has been noted, worth a quick look before signing up
Read my TrimRx review for the full breakdown.
What Is Hers
Hers is the weight-loss vertical of Hims & Hers Health, Inc. (NYSE: HIMS), a large publicly traded company. It offers FDA-approved brand-name medications alongside compounded options, billed through a separate monthly membership.
Hers Pros
- Backed by Hims & Hers Health, Inc. (NYSE: HIMS), a large publicly traded company
- Offers real FDA-approved brand-name medications like Wegovy and Zepbound, not just compounded versions
- Strong BBB record: A+ accreditation and roughly 3.8/5 across thousands of reviews
- Well-documented company history dating back to 2017
Hers Cons
- Mandatory $149/mo membership is billed separately from medication and doesn't guarantee a prescription
- Cheapest compounded semaglutide tier requires a 12-month prepay
- Realistic total monthly cost, membership plus medication, commonly runs $298 or more
- Not available in all 50 states for GLP-1 prescriptions
TrimRx vs. Hers: Key Differences
Medications
Both platforms offer compounded semaglutide and compounded tirzepatide, along with brand-name options like Ozempic, Wegovy, and Zepbound. Semaglutide and tirzepatide have each shown significant weight loss in large clinical trials.[1][2]
Hers leans harder into brand-name access, with options like the Wegovy Pill and Zepbound KwikPen front and center. TrimRx offers brand-name drugs too, but its real strength is the breadth of its compounded oral and injectable menu.
Pricing
This is where the two platforms diverge most. Hers charges a clinical membership of $39 for the first month, then $149/mo, and that fee is separate from the cost of medication itself.
So a Hers patient on compounded semaglutide might pay $149/mo membership plus $199 to $325/mo for the drug, depending on the plan. TrimRx skips the membership entirely and charges one flat price, such as $179/mo for oral compounded semaglutide, with no add-on fee layered underneath.
Hers' cheapest compounded semaglutide tier also requires a 12-month prepay, around $2,388 total, while TrimRx's compounded plans are available month-to-month. For most patients, that structure means a lower and more predictable total cost with TrimRx.
How It Works
Both platforms start with an online intake form. TrimRx routes patients to async or video review by a licensed provider, typically within 24 to 48 hours, then ships through a compounding pharmacy in 3 to 7 days.
Hers uses a similar online questionnaire, but some states require a live video or audio appointment rather than an async review. Hers is also not available in every state for GLP-1 prescriptions specifically.
Customer Sentiment
Hers holds the stronger reputation here. Its BBB rating is A+ with roughly 3.8/5 across about 7,277 reviews, and its Trustpilot score for hims.com sits around 3.4/5.
TrimRx's Trustpilot score is closer to 3.2 to 3.3/5 with mixed feedback, and Reddit commentary tends to be harsher, though much of it is unverified. A recurring Hers complaint is that the $149/mo membership keeps charging even after a patient cancels medication, which catches some people off guard.
My Experience With TrimRx and Hers
Signing up for TrimRx felt straightforward. The intake form was short, and the pricing on the page matched what showed up on the first bill.
There was no surprise membership fee tacked on afterward, which made budgeting simple. Provider review came back within the stated window.
Hers felt more polished on the surface, which makes sense given its size and brand recognition. But the two-part billing took extra reading to understand.
The $149/mo membership charge is easy to miss if you only look at the medication price advertised on the page. Once the actual monthly total was added up, it ran noticeably higher than TrimRx for a comparable compounded plan.
Both providers were responsive and the medical review process felt legitimate on each side. The real difference came down to what the final bill actually looked like each month.
Who Should Choose TrimRx
TrimRx makes the most sense for patients who want a single, predictable monthly price without a separate membership fee. It's also a good fit for anyone who wants to try a compounded plan without committing to a long prepay.
Who Should Choose Hers
Hers is a solid choice for patients who specifically want FDA-approved brand-name medication and value the track record of a large, publicly traded healthcare company. It also suits patients who don't mind paying a membership fee in exchange for that added brand assurance.
Frequently Asked Questions
Is TrimRx or Hers cheaper?
TrimRx is typically cheaper for most patients because it charges one flat monthly price with no membership fee. Hers adds a separate $149/mo membership on top of medication cost, which raises the realistic total.
Is Hers legit?
Yes. Hers is operated by Hims & Hers Health, Inc., a publicly traded company on the NYSE (HIMS), and it holds an A+ BBB accreditation with strong review volume.
What medications does each platform offer?
Both offer compounded semaglutide and compounded tirzepatide alongside brand-name options like Ozempic, Wegovy, and Zepbound. Hers puts more emphasis on brand-name products, while TrimRx offers a broader compounded oral and injectable menu.
Is compounded semaglutide or tirzepatide as effective as the brand-name version?
Compounded versions use the same active ingredient as the brand-name drug, but they are not FDA-approved as finished products the way Ozempic, Wegovy, and Zepbound are. Clinical trial data on effectiveness comes from the brand-name versions of these medications.[1][2]
How does cancellation and billing work?
With Hers, the $149/mo membership can continue to bill even after medication is cancelled, so patients need to cancel that separately. TrimRx bills its flat plan price directly, without a separate membership layer to track.
Summary
Hers brings real strengths to the table: a public company backing it, an A+ BBB rating, and genuine FDA-approved brand-name medication as a first-class option. That track record matters.
Still, TrimRx's flat, transparent pricing and lack of a stacked membership fee make it the better value for most patients shopping for a GLP-1 program in 2026.
References
- Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., ... & Stefanski, A. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/